Another of Publicis Groupe’s health-focused agencies is shaking up its executive team this week, as Saatchi & Saatchi Wellness announced Wednesday the appointments of three new leaders. More: Saatchi & Saatchi Wellness nets new president plus creative and client execs
read moreWhat kind of uptake can Gilead expect for its long-acting HIV prophylactic injection Yeztugo, which was approved last week by the FDA? A HIV physician, who shared her views with analysts from Mizuho Securities, expects that a “majority” of her
read moreWith controversial presentation topics on the docket and the already abbreviated panel suddenly down one member, this week’s meeting of the CDC’s Advisory Committee on Immunization Practices (ACIP) is shaping up to be a long, strange two days. More: New-look
read moreThe commitment is part of a wider pledge to international vaccine alliance Gavi’s upcoming replenishment phase for 2026 through 2030. More: GSK, Bharat Biotech to slash the price of first malaria vaccine to less than per dose by 2028 Source:
read more
This year’s event took place on 11 to 12 June at Manchester Central More: NHS ConfedExpo 2025: a platform for change in UK health and care Source: News
read moreIn one of the first major tests of the new FDA leadership’s regulatory philosophy toward gene therapies for rare diseases, the agency is investigating two Duchenne muscular dystrophy patient deaths following treatment with Sarepta Therapeutics’ Elevidys. More: FDA investigates patient
read more© 1994 - 2026 B.M. Pharmaceuticals